Fenofibrate

Routes
Oral (PO)
Half-Life (t½)
PO: 20h
Formula
C20H21ClO4
Molecular Weight
360.83 g/mol
PubChem CID
3339
Aliases
Tricor, Lipidil

Pharmacological Mechanism

PPARα agonist → increased hepatic fatty-acid oxidation + lipoprotein-lipase transcription → ~50% TG reduction + modest HDL rise. LDL effect modest. Reduces CV events in hypertriglyceridemic diabetic populations (FIELD, ACCORD-Lipid subgroups).

Half-Life & Elimination Curve (PO: 20h)

100%50%25%12.5%0%0h0×t½20h1×t½40h2×t½60h3×t½3.3d4×t½4.2d5×t½0×t½ (0h): 100% remaining (~0.701 mg/L)1×t½ (20h): 50% remaining (~0.351 mg/L)2×t½ (40h): 25% remaining (~0.175 mg/L)3×t½ (60h): 12.5% remaining (~87.7 µg/L)4×t½ (3.3d): 6.3% remaining (~43.8 µg/L)5×t½ (4.2d): 3.1% remaining (~21.9 µg/L)
Plasma (PO)t½ Decay (20h)Effect Site (ke0)
  • 0×t½0h100% (0.701 mg/L)
  • 1×t½20h50% (0.351 mg/L)
  • 2×t½40h25% (0.175 mg/L)
  • 3×t½60h12.5% (87.7 µg/L)
  • 4×t½3.3d6.3% (43.8 µg/L)
  • 5×t½4.2d3.1% (21.9 µg/L)
Elimination t½20h (PO)
Rate Constant (ke)0.0347 h⁻¹
Time to Peak (Tmax)2.5h
Est. Peak (Cmax)0.701 mg/L
Clearance (CL)2.18 L/h
97% Washout (5×t½)4.2d

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References